- Home
- YETI vs KYMR Comparison
YETI vs KYMR Comparison
Compare YETI & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- KYMR
- Stock Information
- Founded
- YETI 2006
- KYMR 2015
- Country
- YETI United States
- KYMR United States
- Employees
- YETI N/A
- KYMR N/A
- Industry
- YETI Recreational Games/Products/Toys
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- YETI Consumer Discretionary
- KYMR Health Care
- Exchange
- YETI Nasdaq
- KYMR Nasdaq
- Market Cap
- YETI 3.2B
- KYMR 2.1B
- IPO Year
- YETI 2018
- KYMR 2020
- Fundamental
- Price
- YETI $31.92
- KYMR $33.45
- Analyst Decision
- YETI Hold
- KYMR Buy
- Analyst Count
- YETI 13
- KYMR 13
- Target Price
- YETI $45.00
- KYMR $56.69
- AVG Volume (30 Days)
- YETI 1.8M
- KYMR 695.8K
- Earning Date
- YETI 05-08-2025
- KYMR 05-01-2025
- Dividend Yield
- YETI N/A
- KYMR N/A
- EPS Growth
- YETI 5.67
- KYMR N/A
- EPS
- YETI 2.05
- KYMR N/A
- Revenue
- YETI $1,829,873,000.00
- KYMR $47,072,000.00
- Revenue This Year
- YETI $8.53
- KYMR $44.93
- Revenue Next Year
- YETI $6.14
- KYMR N/A
- P/E Ratio
- YETI $15.58
- KYMR N/A
- Revenue Growth
- YETI 10.32
- KYMR N/A
- 52 Week Low
- YETI $31.48
- KYMR $29.07
- 52 Week High
- YETI $45.25
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- YETI 27.60
- KYMR 44.68
- Support Level
- YETI $33.36
- KYMR $31.54
- Resistance Level
- YETI $35.91
- KYMR $31.66
- Average True Range (ATR)
- YETI 1.27
- KYMR 2.31
- MACD
- YETI -0.33
- KYMR 0.37
- Stochastic Oscillator
- YETI 6.51
- KYMR 51.20
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.